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Abstract
Background: Ureteral stent removal using an extraction string is advantageous because it can obviate an invasive
cystoscopy, but there is a paucity of data on how patients feel about it, and how bothersome or beneficial it is.
We performed this study to evaluate patients’ preference for stent removal using an extraction string and which
parameters could affect it.
Methods: In total, 114 consecutive patients undergoing ureteral stent insertion after ureteroscopic stone removal
(URS) for unilateral recurrent ureter stones were enrolled. Patients were randomized to a string group or a no string
group.
Stent removal was performed on the first visit within 7 days postoperatively. All patients were asked to complete
the ureteral stent symptom questionnaire, to rate the degree of pain during stent removal using a visual analog
scale (VAS) and to answer to questions regarding their preference.
Results: No significant differences were found in domain total scores including urinary symptoms (p = 0.17), pain
(p = 0.62), general health (p = 0.37), work performance (p = 0.41). However, regarding separate questions for ‘dysuria’
and ‘difficulties with heavy physical activity’, there were significant intergroup differences (p = 0.03 and p = 0.04,
respectively). Particular, a significantly higher proportion of patients in the string group checked ‘stoppage of sexual
intercourse due to stent-related problems’ than in the no string group (p = 0.03).
VAS score on stent removal was significantly higher in the no string group than the string group (p = 0.005).
Among the patients who remember the experience of an indwelling ureteral stent in the past, 85 % (17/20) of
the no string group answered ‘No’ to the question of ‘difference between the methods used in this time and in
the past’. On the contrary, 84.2 % (16/19) answered ‘Yes’ to the same question in the string group. And, all 16
patients of the string group who noted differences between the methods preferred ureteral stent removal using
an extraction string to the past method.
Conclusions: Despite of minor increased morbidity related to the extraction string, patients preferred ureteral
stent removal using the extraction string after URS. The patients with the extraction string felt less pain on stent
removal than flexible cystoscopic stent removal.
Trial registration: KCT0001700. The trial was registered in the Clinical Research
Information Service (CRiS), Republic of Korea; registration date: 18/11/2015.
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Background
Removing a ureteral stent using an extraction string was
first described by Siegel et al. in 1986 as a simple method
to avoid general anesthesia and unnecessary urethral
instrumentation for pediatric patients [1]. Subsequently,
several descriptions of a method to remove ureteral stents
using an extraction string have been published [2–6].
The method is advantageous because it can obviate an
invasive cystoscopic procedure, but there is wide vari-
ability in its clinical application and a paucity of data on
how many urological surgeons use extraction strings,
how patients feel about them, and how bothersome or
beneficial they are.
The ureteral stent is an integral armamentarium in the
urologic surgical field. However, urologists must under-
stand the morbidities related to removing a ureteral
stent and the patients’ perception of stent removal as
well as ureteral stent in situ-related morbidities.
The primary objective of this study was to evaluate pa-
tients’ preference for removing a ureteral stents using an
extraction string. A secondary objective was to evaluate
parameters that could affect patients’ preference using a
visual analog scale (VAS) for pain during ureteral stent
removal and the Ureteral Stent Symptom Questionnaire
(USSQ) with respect to their ureteral stent in situ.
Methods
In total, 114 consecutive patients undergoing insertion
of ureteral stent after ureteroscopic stone removal (URS)
between July 2012 and November 2014 were enrolled.
This study was approved by Bundang Jesaeng General
Hospital Institutional Review Board. Consent was ob-
tained from all patients after providing with verbal and
written information about the study.
Inclusion criteria were patients who had a double J
ureteral stent inserted after URS for unilateral recurrent
ureteral stones. Exclusion criteria were coexisting non-
calculous disease (e.g., malignant obstruction, renal
insufficiency, or congenital anomaly of urinary tract),
solitary kidney, ureteral stricture, pregnancy, or compli-
cated URS requiring long-term stent placement (>7 days).
Patients who were taking an alpha-blocker or anti-
cholinergic agent to treat lower urinary tract symptoms
or who were taking analgesics for chronic pain were also
excluded to rule out any influence of the drugs on the
symptom questionnaire results.
After completing the URS, patients who met the inclu-
sion criteria were randomized into the string-stent group
or the no string-stent group (Fig. 1). Group allocation
was performed using the random-number generator in
Excel 2010 on an operating room computer before stent
insertion.
All stents (6-F Percuflex plus; Boston Scientific, Natick,
MA, USA) were inserted via a retrograde approach under
cystoscopic guidance. Stent lengths were determined
based on patient height. The stent string was manipulated
to leave a new air knot 1 cm from the stent end, as
described by Bockholt et al. [3]. The distal end of the
string (4–5 cm long) was left protruding from the urethral
meatus without securing it to the skin.
All patients were discharged the day following the oper-
ation with prescriptions for prophylactic antibiotics and
non-steroidal anti-inflammatory drugs for several days
until the first visit. Alpha-blockers and anti-cholinergics
were not administered. The string-stent group patients
were reminded to be cautious regarding the string to pre-
vent inadvertent extraction.
Stents were removed in the outpatient department on
the first visit within 7 days postoperatively. All patients
were asked to complete the validated Korean version of
the USSQ [7] immediately before the stent was removed.
Urology residents removed the string-stents by pulling the
string out without use of lidocaine jelly or an analgesic be-
fore the procedure. The no string-stents were removed by
urology residents through flexible cystoscopic procedures
in which 2 % lidocaine jelly was applied in the urethra
without an analgesic. The patient was asked to rate the
degree of pain during stent removal on a 10-cm VAS
(Fig. 1).
We asked the following four questions regarding their
preference:
“Have you ever had an operation to treat urolithiasis?”
“Do you remember your experience with a ureteral
indwelling stent?”
“Was there a difference between the method used this
time and the one used in the past regarding ureteral
stent maintenance and removal?”
“Which method do you prefer?” (Figs. 1 and 2)
Sample size was calculated based on the results of
previous ureteral stent studies. A sample size of 50
patients in each group was sufficient for 80 % power to
detect a 20 % difference in each USSQ domain score.
Statistical analyses were performed using SPSS ver.
19.0 software (SPSS Inc., Chicago, IL, USA). Numerical
data were compared using Student’s t-test. Categorical
data were analyzed using the χ2 test. Statistical signifi-
cance was set at P < 0.05.
Results
In total, 114 patients were randomized into 58 patients in
the string-stent and 56 in the no string-stent groups. No
differences were observed for age, stone size, laterality,
stone location, or in situ ureteral stent duration between
the groups (Table 1).
The USSQ was completed by 89 of 114 patients; 43 in
the string group and 46 in the no string group. The VAS
and the preference questions were completed by all pa-
tients except three patients who had suffered inadvertent
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removal of the string-stent before the first outpatient
clinic visit.
Overall ureteral stent in situ-related symptoms are
shown in Table 2. No significant differences were found
in domain total scores, including urinary symptoms,
pain, general health, or work performance. However, sig-
nificant differences were observed between the groups
for separate questions on “dysuria” and “difficulties with
heavy physical activity” (2.96 vs. 2.36, p = 0.03, and 2.77
vs. 2.18, p = 0.04, respectively). In particular, all patients
who completed the USSQ, except one in the string
group, answered “no active sexual life”. Among them, 22
patients checked “stopped sexual intercourse after inser-
tion of stent ”, which was “due to a stent-related prob-
lem” in 17 patients and was significantly higher than
that in the no string group (77 % vs. 44.4 %, p = 0.03).
Have you ever had an operation to treat urolithiasis in the past?
Yes No
String: 25     String: 30
No string: 23 No string: 33
Do you remember the experience of an indwelling ureteral stent in the past?
Yes No
String: 19 String: 6
No string: 20 No string: 3
Do you think there is any difference between the methods used in this time and in 
the past regarding ureteral stent maintenance and removal?
Yes No
String: 16 String: 3
No string: 3 No string:17
Which method do you prefer?
String No string
The method used this time:   16 2
The method used in the past: 0 1
Fig. 2 Flow diagram of preference questions (String: n = 55, No string: n = 56)
Assessed for eligibility (n=605)




Not meeting inclusion criteria (n=397)
Declined to participate (n=94)
Allocation
Follow up within 7days postoperatively (n=58)
USSQ before stent removal 
VAS after stent removal
Preference questions after stent removal
Follow up within 7days postoperatively (n=56)
USSQ before stent removal 
VAS after stent removal
Preference questions after stent removal
Follow-up
Analyzed (n=55)
Excluded from analysis due to inadvertent
removal of the string-stent (n=3)
Analyzed (n=56)
Analysis
Fig. 1 CONSORT flowchart for this study
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Male patients in the string and no string groups
showed significant higher urinary symptom scores (33.14
vs. 25.87, p = 0.006, and 29.69 vs. 26.26, p = 0.012). No
differences were found between the two sex subgroups
in the other domains of pain, general health, or work
performance (Table 3).
The VAS scores are presented in Table 4. Overall, the
mean pain score was 2.94 in those with string-stents and
4.23 in those with no string-stents who underwent the
flexible cystoscopic removal procedure (p = 0.005).
As shown in Fig. 2, among patients who remembered
their experience with an indwelling ureteral stent in the
past, 85 % (17/20) in the no string group answered “No”
to the question of a “difference between the method
used this time and the one used in the past”. In contrast,
84.2 % (16/19) answered “Yes” to the same question in
the string group. All 16 patients in the string group who
noted a difference between the methods preferred
removal of their ureteral stent using an extraction string
compared to the method used previously.
No significant complications were noted, except three
cases of inadvertent removal of the string-stent before
the first outpatient clinic visit, none of which required
replacement. No patient suffered from a febrile urinary
tract infection requiring additional antibiotic treatment
or a therapeutic procedure (Table 2).
Discussion
The ureteral stent has long been an integral part of
urology, as it reduces postoperative complications, such as
stricture, urine leakage, and renal colic due to edema of
the ureter [8]. However, various in situ-related ureteral
stent problems, such as flank pain, hematuria, and lower
urinary tract symptoms, can develop [9, 10]. Many studies
have assessed how in situ-related stent discomfort can be
alleviated, how long ureteral stents should be in-place,
and the possibility of eliminating use of a ureteral stent
after a ureteroscopic procedure. These studies consistently
show that medications, such as alpha-blocker and anti-
cholinergic agents, only alleviate some in situ-related
ureteral stent symptoms. [11–16] Moreover, ureteral stent
indwelling durations have been shortened [17, 18] and an
indwelling ureteral stent is not required under certain
conditions [19–21].
In addition to in situ-related ureteral stent problems,
urologists must pay more attention to ureteral stent
removal procedures, which are troublesome for patients.
However, few studies have investigated alleviating in
situ-related ureteral stent discomfort. Several reports
have described endoscopic and non-endoscopic methods
intended to reduce pain during cystoscopic stent re-
moval or provide a substitute for the cystoscopic proced-
ure. The ureteral stent extraction string is an alternative
that can obviate the need for a cystoscopic procedure
[1–6, 22, 23].
Most ureteral stents from various manufacturers have
a string connected to the stent, which is used for remov-
ing or intraoperative repositioning of a stent. Some sur-
geons believe the string is useful to avoid an invasive
cystoscopic procedure to remove a stent and reduce
cost. However, others hesitate to use a string-stent due
to possible inadvertent removal or increased stent-
related discomfort or complications. Our result that
84.2 % of the string group found a difference between
methods used this time and previously and 85 % of the
no string group did not find any difference suggests that
the extraction string had not been used popularly in our
study cohort.
In a recent study on ureteral stent extraction strings,
Barnes et al. [4] reported that the index scores for the
USSQ domains of urinary symptoms, pain, general health,
and work performance were not different between the
groups and that use of a stent extraction string after URS
for stone disease did not increase stent-related urinary
symptoms, complications, or morbidity during removal.
In addition to such parameters, our study focused on
evaluating patients’ preference for ureteral stent removal
using an extraction string. As results, we noted that
most patients preferred removal of the ureteral stent
using an extraction string, although there were concerns
about the impact on their sex life and minor increases in
stent-related urinary symptoms, such as dysuria and
difficulties with heavy physical activity. The general
domain scores on the USSQ were not different between
the two groups, except for the questions on “dysuria”
and “difficulties with heavy physical activity”, suggesting
that the stent extraction string only slightly increased
in situ-related stent urinary symptoms or complications.
Male patients showed significantly higher urinary
symptom scores in both groups, suggesting that males
tend to suffer more from urinary symptoms related to a
ureteral stent in situ. This may also result from anatomic
differences between males and females, for example with
respect to the prostate gland and a longer urethra.
Table 1 Patient characteristics
Characteristic String No string P-value
Patients(n) 58 56
Male:Female 42:16 36:20 0.34
Age(years) 50.97±12.20 50.54±14.28 0.86







Stent duration(days) 5.97 6.28 0.12
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Table 2 Overall ureteral stent in situ-related symptoms
Domains Items Scores Standard deviation P
String No string String No string
Urinary symptoms Domain total 30.6 28.2 8.54 7.25 0.17*
Daytime frequency 3.02 3.37 1.14 1.25 0.17*
Nocturia 2.58 2.40 1.07 1.30 0.48*
Urgency 2.21 1.97 1.01 1.11 0.31*
Urge incontinence 1.42 1.33 0.63 0.82 0.59*
Non urge incontinence 1.37 1.16 0.72 0.63 0.14*
Residual urine sensation 3.02 2.60 1.18 1.29 0.11*
Dysuria 2.95 2.36 1.53 1.05 0.03*
Hematuria frequency 3.12 2.80 1.61 1.27 0.31*
Hematuria amount 2.32 2.29 1.06 0.87 0.86*
Interference in life 2.81 2.44 1.31 1.12 0.16*
Quality of life impact 5.76 5.51 1.50 1.31 0.40*
Pain Domain total 21.02 20.40 6.39 5.38 0.62*
Presence or absence of pain 1.23 1.16 0.43 0.37 0.39*
VAS 6.27 5.71 2.84 2.90 0.36*
Pain associated with amount of physical activities 3.20 3.02 1.25 1.32 0.50*
Sleep disturbance 2.20 2.13 1.10 1.04 0.74*
Pain at voiding 3.33 3.09 1.24 1.04 0.34*
Flank pain at voiding 1.37 1.47 0.49 0.50 0.37*
Frequency of painkiller 2.16 2 1.13 0.93 0.46*
Overall bother 3.05 2.84 1.31 1.04 0.42*
General health Domain total 15.12 14.04 5.97 5.09 0.37*
Difficulties with light physical activity 2.23 1.91 1.36 0.99 0.20*
Difficulties with heavy physical activity 2.77 2.18 1.46 1.21 0.04*
Feeling tired 2.33 2.4 1.21 1.18 0.77*
Feeling calm and peaceful 3.40 3.53 1.43 1.42 0.65*
Social life enjoyment 2.88 2.62 1.33 1.34 0.36*
Need extra help 1.51 1.4 0.91 0.86 0.56*
Work performance Domain total 14.41 15.6 6.32 7.04 0.41*
Type of employment 2.30 3.31 2.22 2.65 0.06*
Number of days bed rest all day long 1.79 1.47 2.73 2.30 0.55*
Number of days reduced more than half daily activity 1.80 2.24 1.80 2.64 0.30*
Position or role in workplace 1.81 1.75 0.93 0.84 0.74*
Frequency of rest 1.98 1.08 2.44 1.22 0.06*
Stent related changes on work 2.28 1.98 1.22 1.05 0.22*
Changes in work duration 2.51 2.44 1.45 1.27 0.82*
Sexual matters
No active sexual life: n (%) 42(97.6) 38(82.6) - - 0.02**
Stop of sexual Intercourse after stent: n (%) 22(52) 18(47.3) - - 0.82**
Stop of sexual intercourse due to stent-related problem: n (%) 17(77) 8(44.4) - - 0.03**
Additional problems Need for additional antibiotics (%) 0 0 - - -
Admission or additional therapeutic procedure(%) 0 0 - - -
* Student’s t-test, ** χ2 test.
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Overall VAS scores were different between the string
and no string groups but were more marked in male
than female patients. Barnes et al. [4] reported no differ-
ence in VAS pain scores of patients during stent re-
moval (2.5 in those with a stent string and 3.1 in those
with no string using cystoscopy, p = 0.45). In a small
study that used a VAS to evaluate pain during stent re-
moval using rigid cystoscopy, Kuehhas et al. [24] found
no difference in pain between patients undergoing
cystoscopy and extraction using a stent string. These re-
sults differ from our VAS scores and may have been
influenced by the conditions of our cystoscopic stent
removal procedure, such as use of lidocaine jelly but not
an analgesic. In addition, different clinical experiences
may have caused these differences, as Kuehhas et al.
[24] reported that clinical experience is correlated with
pain scores of cystoscopic procedures. In fact, mean
VAS scores for cystoscopic stent removal were 1.87–8
in several studies. This broad range is thought to be due
to heterogeneous settings, such as type of cystoscope or
whether any adjunctive medications or local anesthesia
was used [4, 24–26].
A few pain-related studies have reported cystoscopic
removal of stents, but the results were obtained under
heterogeneous settings. Large, controlled studies on pain
related to cystoscopic stent removal are warranted.
Loh-Doyle et al. [26] investigated patient experi-
ences of, and preference for, removing ureteral stents
through an anonymous website-based survey that in-
cluded a large sample size and reported the following
results by method : “willingness to undergo the same
procedure again”; cystoscopy in clinic in 51 %,
doctor’s office pulled string in 55 %, cystoscopy in
the operating room in 67 %, and pulling the string
myself in 60 %. We acknowledge the small sample
size of our study and that it was aimed at patients
with recurrent ureteral stones. However, our study
had a relative strength, as it presented the prefer-
ences of a patient cohort that experienced several
procedures. The second limitation was that patients
only had stents in-place for only 7 days after URS.
So, whether this method is useful in cases that re-
quire a stent for a longer period, such as URS for
complicated pyelonephritis, traumatic URS, uretero-
scopic surgery for a ureteral stricture, or periodic
stent changes for a malignant ureteral stricture, is
unknown. Additional studies are necessary to deter-
mine perceptions and related morbidities in patients
who have an indwelling ureteral stent and extraction
string for a longer period.
Table 4 VAS pain scores on ureteral stent removal
VAS score String No string P-value*
Overall 2.94±1.35 4.23±2.45 0.005
Male 3.19±1.09 4.58±2.23 0.006
Female 2.46±1.71 3.54±2.82 0.25
P-value** 0.22 0.11
*between string group and no string group, **between male and female
Table 3 Comparison of ureteral stent in situ-related symptoms between male and female subgroups
Domains String No string P-valuea
Urinary symptoms Overall 30.60 ± 8.54 28.20 ± 7.25 0.17
Male 33.14 ± 7.59 29.69 ± 6.79 0.08
Female 25.87 ± 8.43 26.26 ± 7.56 0.89
P-valueb 0.006 0.012
Pain Overall 21.02 ± 6.39 20.40 ± 5.38 0.62
Male 23.14 ± 6.08 21.58 ± 6.43 0.36
Female 22.27 ± 7.79 21.16 ± 5.51 0.63
P-valueb 0.69 0.82
General health Overall 15.12 ± 5.97 14.04 ± 5.09 0.37
Male 14.93 ± 4.98 13.50 ± 5.42 0.32
Female 15.47 ± 7.68 14.79 ± 4.64 0.75
P-valueb 0.78 0.41
Work performance Overall 14.41 ± 6.32 15.60 ± 7.04 0.41
Male 13.68 ± 6.24 14.50 ± 6.93 0.65
Female 15.80 ± 6.47 17.11 ± 7.12 0.58
P-valueb 0.30 0.22
abetween string group and no string group, bbetween male and female
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Conclusions
Despite a minor increase in morbidity related to the
extraction string, patients preferred removal of their
ureteral stent using an extraction string after URS. The
patients in the extraction string group felt less pain when
the stent was removed than when it was removed with a
flexible cystoscope.
However, appropriate counseling for the minor increase
in morbidities is needed before applying the method
clinically. In particular, concerns related to sexual activity
should be considered for patients with an active sexual
life.
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